Based on the current study, the detection rate of prostate cancer amongst men with PSA>4 ng/ml who underwent TRUS-guided biopsy was 1.8% only (19/1054), raising a concern of the existing PSA threshold that is based on Caucasian populations. The gene discussed is KLK3; the disease is prostate carcinoma.